This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2396) Design and Evaluation of Medical Education Materials (30) Innovations in Cancer Diagnostic and Decision Support (58) Clinical Cancer Research (83) Computer-Aided Diagnosis (122) e-Learning and Medical Education (688) Tools, Programs and Algorithms (265)

Published on in Vol 5, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19408, first published .
e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study

e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study

Authors of this article:

Marloes A Smit1 Author Orcid Image ;   Gabi W van Pelt1 Author Orcid Image ;   Elisabeth MC Dequeker2 Author Orcid Image ;   Raed Al Dieri3 Author Orcid Image ;   Rob AEM Tollenaar1 Author Orcid Image ;   J Han JM van Krieken4 Author Orcid Image ;   Wilma E Mesker1 Author Orcid Image ;   UNITED Group1
Article Authors Cited by (11) Tweetations (1) Metrics

Journals

  1. Ravensbergen C, Kuruc M, Polack M, Crobach S, Putter H, Gelderblom H, Roy D, Tollenaar R, Mesker W. The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer. Cancers 2021;14(1):163 View
  2. Strous M, Faes T, Gubbels A, van der Linden R, Mesker W, Bosscha K, Bronkhorst C, Janssen-Heijnen M, Vogelaar F, de Bruïne A. A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance. Clinical and Translational Oncology 2022;24(6):1047 View
  3. Diederiks N, Ravensbergen C, Treep M, van Wezel M, Kuruc M, Renee Ruhaak L, Tollenaar R, Cobbaert C, van der Burgt Y, Mesker W. Development of Tier 2 LC-MRM-MS protein quantification methods for liquid biopsies. Journal of Mass Spectrometry and Advances in the Clinical Lab 2023;27:49 View
  4. Jakab A, Patai Á, Micsik T. Digital image analysis provides robust tissue microenvironment-based prognosticators in patients with stage I-IV colorectal cancer. Human Pathology 2022;128:141 View
  5. Ravensbergen C, Polack M, Roelands J, Crobach S, Putter H, Gelderblom H, Tollenaar R, Mesker W. Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer. Cells 2021;10(11):2935 View
  6. Hagenaars S, Vangangelt K, Van Pelt G, Karancsi Z, Tollenaar R, Green A, Rakha E, Kulka J, Mesker W. Standardization of the tumor-stroma ratio scoring method for breast cancer research. Breast Cancer Research and Treatment 2022;193(3):545 View
  7. Gao J, Shen Z, Deng Z, Mei L. Impact of Tumor–Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review. Frontiers in Oncology 2021;11 View
  8. Saab M, O’Driscoll M, Sahm L, Leahy-Warren P, Noonan B, FitzGerald S, Kilty C, O’Malley M, Lyons N, Hegarty J. Referring high-risk individuals for lung cancer screening: A systematic review of interventions with healthcare professionals. European Journal of Cancer Prevention 2022;31(6):540 View
  9. Karancsi Z, Hagenaars S, Németh K, Mesker W, Tőkés A, Kulka J. Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens. Virchows Archiv 2024;485(4):703 View
  10. Polack M, Smit M, van Pelt G, Roodvoets A, Meershoek-Klein Kranenbarg E, Putter H, Gelderblom H, Crobach A, Terpstra V, Petrushevska G, Gašljević G, Kjær-Frifeldt S, de Cuba E, Bulkmans N, Vink G, Al Dieri R, Tollenaar R, van Krieken J, Mesker W, Petrushevska G, Bogdanovska M, Zdravkoski P, Antovic S, Dzambaz D, Karagjozov P, de Cuba E, Beverdam F, Jansen J, Vermaas M, Gašljević G, Kjær-Frifeldt S, Lindebjerg J, Strous M, Vogelaar J, Bulkmans N, van Baarlen J, Mekenkamp L, Hoekstra R, Sie M, Cuatrecasas M, Simonetti S, Rodrigo M, Sanz I, Guerrero Pineda J, Leeuwis-Fedorovich N, Talsma K, Souza da Silva R, Lacle M, Koopman M, Dekker J, van Tilburg A, Nuciforo P, Villalobos Alberú X, Landolfi S, Zucchiatti A, Witteveen E, Bordbar A, Hendriks M, Arensman R, Natu S, Maka N, Mesker W, Tollenaar R, Polack M, Smit M, van Pelt G, Putter H, Meershoek-Kleinenbarg E, Roodvoets A, Crobach A, Gelderblom H, Fontes e Sousa M, Borralho Nunes P, Cruz J, Raimundo A, Silva N, Brito M, Terpstra V, Zakhartseva L, Al Dieri R, Fléjou J, Feakins R, Dequeker E, Vink G, van Krieken J. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer. ESMO Open 2024;9(4):102988 View
  11. Knight K, Bigley C, Pennel K, Hay J, Maka N, McMillan D, Park J, Roxburgh C, Edwards J. The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer. The Journal of Pathology: Clinical Research 2024;10(4) View